- Vessel — a new at-home wellness tracker that helps users access, understand, and optimize health and wellness from the comfort of home — announced it has raised $8 million in funding. These are the details.
Vessel — a new at-home wellness tracker that helps users access, understand, and optimize health and wellness from the comfort of home — announced it has raised $8 million in funding. Including this round, the company has raised total seed funding of $14.5 million.
This round of funding is being led by Monogram Capital Partners, a leading consumer growth firm. And additionally, the round includes participation from Able, BFG, Cove, and Sidekick along with angel investors Dave Asprey (Bulletproof 360 Founder), Jared Leto (actor), Jarret John “JJ” Thomas (pro snowboarder), and Kelly Slater (pro surfer). Vessel launched in November 2020 and sold more than 100,000 test cards.
Vessel enables members to test 10 different health metrics in less than 10 minutes for around $10. Users simply urinate on one of Vessel’s wellness cards, scan the card using the Vessel app, and receive their “low,” “good,” or “high” biomarker ratings to determine what may be affecting things like their energy, stress, and immunity.
Biomarkers tested include Vitamin B7 (Biotin), Vitamin B9 (Folate), hydration, Vitamin C, Cortisol, Magnesium, Ketone A (AcAc), Ketone B (BHB), pH, Creatinine, and Calcium. And the app then provides tailored plans to help users instantly understand what nutrition and lifestyle changes will make the biggest impact for them. There are daily, weekly, and monthly membership packages available so users can try out their custom recommendations and then continue to test over time to see if those changes are making a difference. Vessel recommends weekly testing, which is available for as low as $35 per month.
“Vessel’s technology enables people to assess their health and wellbeing from the comfort of their own homes at a time when the focus on wellness optimization has never been more prescient. We are strong believers in the shift toward at-home diagnostics as the next wave of innovation enabling consumers to assess and optimize their personalized nutrition needs on a far more real-time basis than the traditional annual doctor’s check-up. I believe Vessel is extremely well-positioned to lead the way in this space and look forward to seeing the company grow as it continues to add even further functionality to its offering and build an integrated ecosystem of health services around it.”
— Jared Stein, Co-Founder & Partner of Monogram Capital
“The science is clear: our bodies perform better when we optimize them. I’ve experienced how impactful testing and optimizing your nutrient levels can be when it comes to sleep, energy, and brain function. Now, anyone can make meaningful changes without a trip to the doctor or spending thousands of dollars on lab work. The feedback we are getting from customers is phenomenal; they are feeling a difference in a matter of weeks. The support of Monogram Capital, Able, BFG, Sidekick, Cove and MVP authenticates our mission to help people around the world feel and perform better.”
— Jon Carder, Founder and CEO of Vessel